Search

everythinglearnresearchcommunity

for

Search:↓

Hair and wool strength is affected by the number and type of bonds in their protein structures, with hair having more protein aggregates than wool.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Spironolactone treatment increases the amount of testosterone available in the body.

Selenoproteins are crucial for healthy skin and hair.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

FOXN1 gene variants cause low T cells and immune issues from birth.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

NFIC helps rat dental cells grow and turn into bone-like cells.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Polyquaternium 7® builds up on hair, improving its look and feel, and AFM is good for measuring these changes.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.